Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib for rheumatoid arthritis with peripheral neuropathy (multicenter cohort study)
ChiCTR2000034690Phase 4Recruiting
- Sponsor
- Shenzhen Traditional Chinese Medicine Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tofacitinib in rheumatoid arthritis (RA) and peripheral neuropathy (2 arms), sponsored by Shenzhen Traditional Chinese Medicine Hospital. Primary endpoint: Peripheral nerve conduction effectiveness by neurophysiology. Started Jul 2020; status: recruiting.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)peripheral neuropathy
Beyond the preview
Go deeper on ChiCTR2000034690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034690.